Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q28202172)
Watch
English
Quinupristin/dalfopristin: a therapeutic review
scientific article (publication date: 2001)
In more languages
edit
Statements
instance of
scholarly article
0 references
review article
1 reference
stated in
Europe PubMed Central
title
Quinupristin/dalfopristin: a therapeutic review
(English)
0 references
author name string
D R Allington
series ordinal
1
0 references
M P Rivey
series ordinal
2
0 references
language of work or name
English
0 references
publication date
January 2001
0 references
published in
Clinical Therapeutics
0 references
volume
23
0 references
issue
1
0 references
page(s)
24-44
0 references
cites work
Quinupristin/dalfopristin, a new addition to the antimicrobial arsenal
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A novel antimicrobial agent joins the battle against resistant bacteria
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical implications of nosocomial gram-positive bacteremia and superimposed antimicrobial resistance
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An overview of nosocomial infections, including the role of the microbiology laboratory
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Methicillin-resistant Staphylococcus aureus: long-term care concerns
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in North America
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gram-positive resistance: challenge for the development of new antibiotics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Streptogramins: an answer to antibiotic resistance in gram-positive bacteria
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Current and future management of infections due to methicillin-resistant staphylococci infections: the role of quinupristin/dalfopristin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Optimal treatment of complicated skin and skin structure infections
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activity of quinupristin/dalfopristin against gram-positive bacteria: clinical applications and therapeutic potential
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacodynamic analysis of the activity of quinupristin-dalfopristin against vancomycin-resistant Enterococcus faecium with differing MBCs via time-kill-curve and postantibiotic effect methods.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Occurrence and epidemiology of resistance to virginiamycin and streptogramins
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics of quinupristin-dalfopristin in continuous ambulatory peritoneal dialysis patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bactericidal and inhibitory activity of quinupristin/dalfopristin against vancomycin- and gentamicin-resistant Enterococcus faecium
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In-vitro activity of quinupristin/dalfopristin compared with other widely used antibiotics against strains isolated from patients with endocarditis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A review of in-vitro antibacterial activity of quinupristin/dalfopristin against methicillin-susceptible and -resistant Staphylococcus aureus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. Sentry Participants Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxa
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quinupristin/dalfopristin: therapeutic potential for vancomycin-resistant enterococcal infections
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activity of quinupristin/dalfopristin and its components against Haemophilus influenzae
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Synergic activity of vancomycin-quinupristin/dalfopristin combination against Enterococcus faecium
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Postantibiotic effect and postantibiotic sub-MIC effect of quinupristin-dalfopristin against gram-positive and -negative organisms.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prospective, randomized dose-ranging open phase II pilot study of quinupristin/dalfopristin versus vancomycin in the treatment of catheter-related staphylococcal bacteremia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Synercid Emergency-Use Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infect
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety and tolerability of quinupristin/dalfopristin: administration guidelines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980028-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0149-2918(01)80028-X
0 references
PubMed publication ID
11219478
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
